Theriva Biologics announces 1-for-25 reverse stock split effective Aug 26, 2024

Theriva Biologics, Inc.

Reverse split at 1-for-25 ratio; outstanding shares reduce from ~25.1M to ~1.0M.
Effective 12:01 a.m. ET on Aug 26, 2024; trading on split-adjusted basis same day.
Split intended to meet NYSE American per-share price listing requirements.
No fractional shares issued; holders of fractional shares get rounded up to next whole share.
CUSIP changes to 87164U 508; ticker remains TOVX.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.